Browse > Article

Polymorphisms of the CTLA-4 promoter(-318) and exon 1(+49) genes with atopic dermatitis in Korean children  

Song, Tae Won (Department of Pediatrics and Institute of Allergy, BK21 Project for Medical Science, Yonsei University College of Medicine)
Yang, Hea Sun (Department of Pediatrics and Institute of Allergy, BK21 Project for Medical Science, Yonsei University College of Medicine)
Lee, Kyung Eun (Department of Pediatrics and Institute of Allergy, BK21 Project for Medical Science, Yonsei University College of Medicine)
Kim, Kyung Won (Department of Pediatrics and Institute of Allergy, BK21 Project for Medical Science, Yonsei University College of Medicine)
Kim, Eun Soo (Department of Pediatrics and Institute of Allergy, BK21 Project for Medical Science, Yonsei University College of Medicine)
Sohn, Myung Hyun (Department of Pediatrics and Institute of Allergy, BK21 Project for Medical Science, Yonsei University College of Medicine)
Kimc, Kyu-Earn (Department of Pediatrics and Institute of Allergy, BK21 Project for Medical Science, Yonsei University College of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.49, no.5, 2006 , pp. 545-551 More about this Journal
Abstract
Purpose : The gene-encoding cytotoxic T lymphocyte-associated antigen-4(CTLA-4) is one of the candidate genes for conferring susceptibility to atopic dermatitis(AD). The aim of the study was to investigate the association between Korean children with AD and the polymorphisms of CTLA-4 gene promoter(-318) and exon 1(＋49). Methods : The CTLA-4 promoter(-318 T/C) and exon 1(＋49 A/G) polymorphisms were genotyped via restriction fragment length polymorphism methods in 145 children with atopic eczema, 69 children with non-atopic eczema, and 96 healthy controls. Results : There was no significant difference in genotype and allele frequencies of the CTLA-4 promoter -318 T/C and exon 1 ＋49 A/G polymorphisms when the atopic eczema, non-atopic eczema, and control groups were compared. Additionally the CTLA-4 promoter -318 T/C and exon 1 ＋49 A/G polymorphisms were not shown to be associated with severity, IgE level, or eosinophil counts. Conclusion : Our data show that the polymorphisms within the CTLA-4 promoter(-318 T/C) and exon 1(＋49 A/G) genes are not associated with susceptibility to AD in Korean children.
Keywords
Atopic dermatitis; CTLA-4; Polymorphism;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Howard TD, Postma DS, Hawkins GA, Koppelman GH, Zheng SL, Wysong AK, et al. Fine mapping of an IgEcontrolling gene on chromosome 2q: Analysis of CTLA4 and CD28. J Allergy Clin Immunol 2002;110:743-51   DOI   ScienceOn
2 Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993;366:76-9   DOI   ScienceOn
3 Liu X, Bai XF, Wen J, Gao JX, Liu J, Lu P, et al. B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(＋) T lymphocytes in vivo. J Exp Med 2001;194:1339-48   DOI
4 Boussiotis VA, Freeman GJ, Gribben JG, Daley J, Gray G, Nadler LM. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc Natl Acad Sci USA 1993;90:11059-63   DOI
5 Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 1996; 5:1075-80   DOI
6 Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 1997;337:1720-5   DOI   ScienceOn
7 Lee YH, Choi SJ, Kim YR, Ji JD, Song GG. Polymorphism of CTLA-4 exon 1 and promoter genes in systemic lupus erythematosus and rheumatoid asthritis. J Korean Rheum Assoc 2000;7:53-61
8 Takeuchi F, Kawasugi K, Nabeta H, Mori M, Tanimoto K. Association of CTLA-4 with systemic sclerosis in Japanese patients. Clin Exp Rheumatol 2002;20:823-8
9 Hong SJ, Lee MS, Sohn MH, Shim JY, Han YS, Ahn YM, et al. Self-reported prevalence and risk factors of asthma among Korean adolescents : 5-year follow-up study, 1995-2000. Clin Exp Allergy 2004;34:1556-62   DOI
10 Kapp A, Gilitzer H, Schopf E. Production of interferon and lymphoproliferative responses in whole blood culture derived from patient with atopic dermatitis. Arch Dermatol Res 1987;279:55-8   DOI
11 Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, Ban Y, et al. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 1997; 7:843-6   DOI
12 Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M, Suzan M, Mattei MG, et al. A new member of the immunoglobulin superfamily, CTLA-4. Nature 1987;328:267-70   DOI   ScienceOn
13 Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991;174:561-9   DOI   ScienceOn
14 Ling V, Wu PW, Finnerty HF, Agostino MJ, Graham JR, Chen S, et al. Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches. Genomics 2001;78:155-68   DOI   ScienceOn
15 Lafage-Pochitaloff M, Costello R, Couez D, Simonetti J, Mannoni P, Mawas C, et al. Human CD28 and CTLA-4 Ig superfamily genes are located on chromosome 2 at bands q33-q34. Immunogenetics 1990;31:198-201
16 Leung DYM. Atopic dermatitis : New insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;105:860-76   DOI   ScienceOn
17 Kawashima T, Noguchi E, Arinami T, Yamakawa-Kobayashi K, Nakagawa H, Otsuka F, et al. Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med Genet 1998;35:502-4   DOI
18 Wang XB, Zheng CY, Giscombe R, Lefvert AK. Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells. Scand J Immunol 2001;54:453-8   DOI   ScienceOn
19 Chan SC, Brown MA, Willcox TM, Li SH, Stevens SR, Tara D, et al. Abnormal IL-4 gene expression by atopic dermatitis T lymphocytes is reflected in altered nuclear protein interactions with IL-4 transcriptional regulatory element. J Invest Dermatol 1996;106:1131-6   DOI   ScienceOn
20 Yang KD, Liu CA, Chang JC, Chuang H, Ou CY, Hsu TY, et al. Polymorphism of the immune-braking gene CTLA-4 (＋49) involved in gender discrepancy of serum total IgE levels and allergic disease. Clin Exp Allergy 2004;34:32-7   DOI
21 Walunas TL, Bluestone JA. CTLA-4 regulates tolerance induction and T cell differentiation in vivo. J Immunol 1998; 160:3855-60
22 Hudson LL, Rocca K, Song YW, Pandey JP. CTLA-4 gene polymorphisms in systemic lupus erythematosus : a highly significant association with a determinant in the promoter region. Hum Genet 2002;111:452-5   DOI   ScienceOn
23 Sampson HA. Role of immediate hypersensitivity in the pathogenesis of atopic dermatitis. Allergy 1989;44(Suppl 9): 52-8
24 Mora B, Bonamico M, Indovina P, Megiorni F, Ferri M, Carbone MC, et al. CTLA-4 +49 A/G dimorphism in Italian patients with celiac disease. Hum Immunol 2003;64:297-301   DOI   ScienceOn
25 Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich-Kautzky E, et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994;264:1152-6   DOI
26 Hanifin J, Rajka G. Diagnostic features of atopic dermatitis. Acta Derma Venereol 1980;92:44-7
27 Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA Jr, Lombard LA, et al. Cloning of B7-2 : a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993;262:909-11   DOI
28 European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis : The SCORAD Index. Dermatol 1993;186:23-31   DOI   ScienceOn
29 Wang XB, Zhao X, Giscombe R, Lefvert AK. A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein. Genes Immun 2002;3:233-4   DOI   ScienceOn
30 Lee SY, Lee YH, Shin C, Shim JJ, Kang KH, Yoo SH, et al. Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene. Chest 2002;122:171-6   DOI
31 Noel PJ, Boise LH, Thompson CB. Regulation of T cell activation by CD28 and CTLA4. Adv Exp Med Biol 1996;406: 209-17
32 Wollenberg A, Kraft S, Oppel T, Bieber T. Atopic dermatitis : pathogenetic mechanism. Clin Exp Dermatol 2000;25: 530-4   DOI   ScienceOn
33 Pavkovic M, Georgievski B, Cevreska L, Spiroski M, Efremov DG. CTLA-4 exon 1 polymorphism in patients with autoimmune blood disorders. Am J Hematol 2003;72:147-9   DOI   ScienceOn
34 Munthe-Kaas MC, Carlsen KH, Helms PJ, Gerritsen J, Whyte M, Feijen M, et al. CTLA-4 polymorphism in allergy and asthma and the Th1/Th2 paradigm. J Allergy Clin Immunol 2004;114:280-7   DOI   ScienceOn